A detailed history of First Citizens Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, First Citizens Financial Corp holds 2,596 shares of AZN stock, worth $170,375. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,596
Previous 2,596 -0.0%
Holding current value
$170,375
Previous $202,000 -0.0%
% of portfolio
0.11%
Previous 0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$66.81 - $80.83 $173,438 - $209,834
2,596 New
2,596 $202,000
Q4 2022

Jan 11, 2023

BUY
$54.21 - $70.44 $166,695 - $216,603
3,075 New
3,075 $208,000
Q1 2022

Apr 18, 2022

BUY
$55.72 - $67.12 $171,339 - $206,394
3,075 New
3,075 $204,000
Q1 2021

Apr 09, 2021

SELL
$47.16 - $54.44 $241,694 - $279,005
-5,125 Closed
0 $0
Q2 2020

Jul 30, 2020

SELL
$43.1 - $55.31 $30,170 - $38,717
-700 Reduced 12.02%
5,125 $271,000
Q4 2019

Jan 21, 2020

BUY
$42.46 - $50.46 $247,329 - $293,929
5,825 New
5,825 $290,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track First Citizens Financial Corp Portfolio

Follow First Citizens Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Financial Corp with notifications on news.